PubMed · 1983392
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
M A Abas, S W Acuda, J C Broadhead, I V Chagwedera, F B Chikara, J M Piachaud, M Stefanovio, J Vermeulen. 1990. WHO consensus statement.. https://pubmed.ncbi.nlm.nih.gov/1983392/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
PURPOSE: Pharmacology of atypical antipsychotics and the clinical implications are reviewed. SUMMARY: Psychiatric disorders, such as schizophrenia and bipolar disorder, are often associated with poor outcomes. Atypical antipsychotics have become the standard of care for these disorders, and multiple agents have demonstrated efficacy for both acute and maintenance therapy. As a result of their differential pharmacologic properties, atypical antipsychotics have diverse clinical profiles, resulting in different liabilities for specific adverse events. These effects can, in turn, have an adverse impact on patient functionality, adherence to therapy, and overall health. CONCLUSION: Atypical antipsychotics have distinct pharmacological profiles which result in clinically meaningful differences in adverse effects. Clinicians should have a wide choice of agents available with which to optimize outcomes in the majority of patients with psychiatric disorders.
Explore the source record for details and available documents.
Explore the source record for details and available documents.